Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lung cancer
Phenotype |nsclc
Sentences 62
PubMedID- 22164285 Among the several pathologies currently treated with cddp, non-small cell lung carcinoma (nsclc), a subtype of lung cancer, is one of the most challenging, due to the high ratio of refractory patients to the current therapy (for a review see [2]).
PubMedID- 26035298 nsclc accounts for ~85% of all lung cancer cases (30) and remains the leading cause of cancer-related death worldwide (31).
PubMedID- 24212667 One particular mirna family, the mir-29 family (comprising mir-29a, -29b, and -29c) has been shown to directly target dnmt3a and -3b and indirectly dnmt1 [25-27], in this regard, the mir-29 family was found to be downregulated in nsclc and enforced expression of mir-29s in lung cancer cell lines restored normal patterns of dna methylation, induced reexpression of methylation-silenced tumor suppressor genes, and inhibited tumorigenicity in vitro and in vivo [25] (table 1).
PubMedID- 24695790 nsclc is any type of epithelial lung cancer other than small cell lung carcinoma (sclc), so we used 16hbe-t which is an immortalized human bronchial epithelial cell line to serve as control for nsclc cell lines.
PubMedID- 22263075 Non small cell lung cancer (nsclc) accounts approximately 80-85% of all lung cancer diagnosis; the majority of patients will be diagnosed with non operable, advanced-stage disease.
PubMedID- 25730907 As for nsclc, about 22%–64% of advanced lung cancer patients will eventually develop bone metastasis [35].
PubMedID- 25709440 Non-small cell lung carcinoma (nsclc), accounting for 80% of all lung cancers, is a lethal lung disorder because of uncontrollable tumor cell growth and consequent metastasis, invasion of adjacent tissue, and loss of lung function.1–3 according to a recent report, nsclc is expected to cause more than 30% of all cancer-related deaths throughout the world in the near future.4 the conventional therapeutic regimen for nsclc is combined application of surgery and chemotherapy.5 although the majority of solid tumors are able to be removed surgically, chemotherapy is still of great importance for the destruction of residual tumor cells in the body.
PubMedID- 26147394 The nsclc, account for 85% of the lung cancer incidence, and can be further subdivided into three groups: adenocarcinoma, squamous cell carcinoma and large cell carcinoma.
PubMedID- 26285137 nsclc accounts for 80% of lung cancer.
PubMedID- 23441611 nsclc represents the majority of human lung cancers (8).
PubMedID- 23833645 Non-small cell lung carcinoma (nsclc) accounted for ∼85% of the all lung cancer cases (2).
PubMedID- 23585862 While surgical resection is the most effective therapy in nsclc, 75% of patients with lung cancer present with unresectable disease.

Page: 1 2